QIAGEN’s Proposed €9.6 Billion Takeover Requires Transaction and Compliance Planning

On 21 October, EQT’s acquisition vehicle announced a voluntary cash offer of €46.50 per QIAGEN share, valuing the Dutch-headquartered life-sciences company’s equity at approximately €9.6 billion. The takeover is proposed, and no separate legal-advisory or compliance-services contract price was disclosed. Corporate legal teams, investors and compliance advisers can explore digital due diligence, document analytics and transaction-monitoring workflows; HPC can support secure data processing and audit reporting, with quotations based on the confirmed engagement scope.

If you are interested to enquire further, please fill in the form below with your details and one of our consultants will contact you shortly.